Free Trial
NASDAQ:CUPR

Cuprina Holdings (Cayman) Q4 2025 Earnings Results & Report

Cuprina Holdings (Cayman) logo
$1.99 +0.09 (+4.74%)
Closing price 10/14/2026 04:00 PM Eastern
Extended Trading
$1.99 0.00 (0.00%)
As of 08:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cuprina Holdings (Cayman) reported Q4 2025 earnings on April 27, 2026. The company reported EPS of -$0.40, while revenue was $0.01 million.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
Before Market Opens

Cuprina Holdings (Cayman) EPS Results

Actual EPS
-$0.40
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cuprina Holdings (Cayman) Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Cuprina Holdings (Cayman) Q4 2025 Earnings FAQ

Cuprina Holdings (Cayman) (NASDAQ:CUPR) reported earnings of -$0.40 per share for Q4 2025. The report was announced on Monday, April 27, 2026.

Cuprina Holdings (Cayman) reported revenue of $0.01 million for Q4 2025.

Cuprina Holdings (Cayman) Earnings Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
CUPR - Cuprina Holdings (Cayman) Limited
See More Cuprina Holdings (Cayman) Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cuprina Holdings (Cayman)? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cuprina Holdings (Cayman) and other key companies, straight to your email.

About Cuprina Holdings (Cayman)

Cuprina Holdings (Cayman) (NASDAQ:CUPR) Limited is a medical technology company focused on developing and commercializing products for wound care and related medical applications. The company’s technologies are designed to support the management of wounds, including products intended to help control bleeding and promote the healing process.

Cuprina’s product portfolio is based on biomaterials and biological components, including technologies derived from animal blood, and is intended for use by healthcare professionals in clinical and surgical settings. Its offerings are designed to address unmet needs in wound management and may be used across a range of healthcare applications.

The company is headquartered in Singapore and serves healthcare markets through commercial and distribution activities in multiple jurisdictions. Cuprina Holdings is incorporated in the Cayman Islands and its ordinary shares trade on the Nasdaq Capital Market under the symbol CUPR.

View Cuprina Holdings (Cayman) Profile